idiopathic retinal vasculitis, aneurysm, neuroretinitis: a significant increase in visual acuity after treatment with one session of panretinal photocoagulation, retinopexy and three consecutive intravitreal bevacizumab (avastin) injection

نویسندگان

هوشنگ فقیهی

hooshang faghihi مونا سید صفی زاده

mona seyed safizadeh شاهین فقیهی

shahin faghihi هومن فقیهی

houman faghihi

چکیده

purpose: to report an idiopathic retinal vasculitis, aneurysm, neuroretinitis (irvan) case treated with one session of panretinal photocoagulation (prp) and intravitreal bevacizumab (avastin) case report: a 13-year-old boy was diagnosed as an irvan syndrome. systemic examination, fundus angiography, brain mri were performed to evaluate the patient. treatment with one session of prp, retinopexy and 3 consecutive monthly intravitreal injection of 1.25 mg bevacizumab was performed. after the second bevacizumab injection, complete regression of neovascularizations and improvement of visual acuity (va) to 3/10 for right eye and 6/10 for left eye was noted. by the other 2 additional monthly intravitreal injection of bevacizumab, va improved to 6/10 and 8/10 for right and left eye. the aneurysms became smaller. after 6 months of his treatment, his va was remained stable. conclusion: we reported a successful treatment effect of bevacizumab as an adjunctive therapy in combination with prp and retinopexy, for stage 3 irvan. bevacizumab seems to have promising effects in the treatment of irvan.   iranian journal of ophthalmology 201224(2):65-71 © 2012 by the iranian society of ophthalmology

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.

PURPOSE To evaluate the efficacy of intravitreal injection of bevacizumab (Avastin) (IVA) in preventing panretinal photocoagulation (PRP)-induced macular thickening and visual dysfunction in eyes with severe proliferative diabetic retinopathy. METHODS A retrospective review of 60 consecutive eyes (30 patients) with severe proliferative diabetic retinopathy whose visual acuity was 20/30 or bet...

متن کامل

Intravitreal Bevacizumab for Macular Edema from Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis.

To assess the potential visual benefit of intravitreal bevacizumab in a patient with macular edema from idiopathic retinal vasculitis, aneurysms, and neuroretinitis, an intravitreal injection of bevacizumab (1.25 mg) was given. Within 1 week, visual acuity improved from 20/60 to 20/30 and optical coherence tomography demonstrated resolution of macular edema. There was no adverse effect. The mac...

متن کامل

Intravitreal Injection of Bevacizumab (Avastin) to Treat Posterior Capsule Neovascularization

We report a 64-year-old diabetic woman who developed neovascularization of the posterior capsule 2 years after cataract surgery and intraocular lens implantation. The patient was treated with single injection of 1.25 mg of intravitreal bevacizumab (Avastin) via pars plana. After one week, complete regression of the posterior capsule neovascularization was achieved allowing us to perform Nd: YAG...

متن کامل

[Intravitreal injection of bevacizumab (Avastin) for retinal angiomatous proliferation].

CLINICAL CASE An 81-year-old man presented with stage 2 retinal angiomatous proliferation (RAP) as identified by fluorescein angiography and optical coherence tomography (OCT), and was shown to have a visual acuity (VA) of 20/40. One week after an intravitreal injection of bevacizumab (1.25 mg) the VA improved to 20/25, and the OCT showed a reduction of both intraretinal edema and pigment epith...

متن کامل

Comparison between panretinal photocoagulation and panretinal photocoagulation plus intravitreal bevacizumab in proliferative diabetic retinopathy.

BACKGROUND Patients with diabetes often develop ocular complications. The most common and most blinding of these complications, however, is diabetic retinopathy. The objective of this study was to compare the retinal neovessels regression in Proliferative Diabetic Retinopathy (PDR) treated with Pan Retinal Photocoagulation (PRP) versus panretinal photocoagulation plus Intra Vitreal Bevacizumab ...

متن کامل

Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy

OBJECTIVE To compare effectiveness of pan-retinal photocoagulation alone versus panretinal photocoagulation combined with intravitreal bevacizumab on visual acuity and central macular thickness in patients presenting with proliferative diabetic retinopathy. METHODS This Randomized controlled trial was carried out at Armed Forces Institute of ophthalmology, Pakistan from Jan 2016 to Aug 2016. ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
journal of current ophthalmology

جلد ۲۴، شماره ۲، صفحات ۶۵-۷۱

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023